Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen

European Journal of Surgical Oncology

Volumn 37, Issue 12, 2011, Pages 1051-1058

  Kontos, M ^a   Allen, D S ^a   Agbaje, O F ^a   Hamed, H ^a   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Loco regional relapse; Older patients; Randomised trial; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; TUMOR NECROSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MEDICAL RECORDS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SALVAGE THERAPY; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 80955144237     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.07.005     Document Type: Article

References (33)

1. O. Møller Jensen, J. Estve, H. Møller, and H. Renard Cancer in the European Community and its member states Eur J Cancer 26 1990 1167 1256
2. K.C. Chu, R.E. Tarone, and L.G. Kessler Recent trends in U.S. breast cancer incidence, survival, and mortality rates J Natl Cancer Inst 88 1996 1571 1579
3. J. Samet, W.C. Hunt, and C. Key Choice of cancer treatment varies with age of patient J Am Med Assoc 255 1986 1302 1307
4. R. Ballard-Barbash, A.L. Potosky, L.C. Harlan, S.G. Nayfield, and L.G. Kessle Factors associated with surgical and radiation therapy for early stage breast cancer in older women J Natl Cancer Inst 88 1996 716 726
5. M.M. Kemeny, B.L. Peterson, and A.B. Kornblith Barriers to clinical trial participation by older women with breast cancer J Clin Oncol 21 2003 2268 2275
6. J.C. Gazet, H.T. Ford, and R.C. Coombes Prospective randomized trial of tamoxifen vs surgery in older patients with breast cancer Eur J Surg Oncol 20 1994 207 214
7. M. Fennessy, T. Bates, and K. Macrae Late follow-up of a randomised trial of surgery plus tamoxifen versus tamoxifen alone in women over 70 years with operable breast cancer Br J Surg 91 2004 699 704
8. J.F. Robertson, I.O. Ellis, C.W. Elston, and R.W. Blamey Mastectomy or tamoxifen as initial therapy for operable breast cancer in older patients: 5-year follow-up Eur J Cancer 28 1992 908 910
9. I.S. Fentiman, J. van Zijl, and I. Karydas Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen Eur J Cancer 39 2003 300 308
10. J.C.J.M. De Haes, D. Curran, N.K. Aaronson, I.S. Fentiman On behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Breast Cancer Cooperative Group (BCCG) Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial Eur J Cancer 39 2003 945 951
11. J.A. van Dongen, H. Bartelink, and I.S. Fentiman Factors influencing local relapse and survival and results of salvage treatment after breast conserving therapy in operable breast cancer; EORTC 10801 trial comparing breast conservation with mastectomy in TNM Stage I and II breast cancer Eur J Cancer 28 1992 801 804
12. B. Fisher, and C. Redmond Lumpectomy for breast cancer: an update of the NSABP experience. National surgical adjuvant breast and bowel project J Natl Cancer Inst Monographs 11 1992 7 13
13. J. Chakrabarti, F.S. Kenny, B.M. Syed, J.F.R. Robertson, R.W. Blamey, and K.L. Cheung A randomised trial of mastectomy only versus tamoxifen for treating elderly patients with operable primary breast cancer - final results at 20-year follow-up Crit Rev Oncol Hematol 2010 10.1016/j.critrevonc.2010.04.006
14. K.J. Halverson, C.A. Perez, R.R. Kuske, D.M. Garcia, J.R. Simpson, and B. Fineberg Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis Int J Radiat Oncol Biol Phys 23 1992 285 291
15. C. Kamby, and L. Sengelov Survival and pattern of failure following locoregional recurrence of breast cancer Clin Oncol (R Coll Radiol) 11 1999 156 163
16. A. Rhodes, B. Jasani, and K.D. Miller Frequency of estrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening J Clin Pathol 53 2000 688 696
17. R. Yaghan, P.D. Stanton, K.W. Robertson, J.J. Going, G.D. Murray, and C.S. McArdle Estrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer Eur J Surg Oncol 24 1998 424 426
18. A. Wallgren, M. Bonetti, R.D. Gelber, and J. Collins International breast cancer study group trials I through VII. Risk factors for locoregional recurrence among breast cancer patients: results from international breast cancer study group trials I through VII J Clin Oncol 21 2003 1205 1213
19. S.E. Pinder, I.O. Ellis, M. Galea, S. O'Rouke, R.W. Blamey, and C.W. Elston Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up Histopathology 24 1994 41 47
20. C.J. Fisher, M.K. Egan, P. Smith, K. Wicks, R.R. Millis, and I.S. Fentiman Histopathology of breast cancer in relation to age Br J Cancer 75 1997 593 596
21. P.P. Rosen, M.L. Lesser, and D.W. Kinne Breast carcinoma in extremes of age: a comparison of patients younger than 35 years and older than 75 years J Surg Oncol 28 1985 90 96
22. S.E. Singletary Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy Am J Surg 184 2002 383 393
23. L. Assersohn, T.J. Potts, S. Ashley, A.G. Nash, and N. Naziri Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy Ann Oncol 10 1999 1451 1455
24. U. Veronesi, B. Salvadori, and F. Rilke Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients Eur J Cancer 31 1995 1574 1579
25. E. Shin, Y. Takatsuka, and Y. Okamura A retrospective study of breast cancer patients treated with quadrantectomy without radiation therapy Breast Cancer 25 1999 109 116
26. M. Deutsch Radiotherapy after lumpectomy for breast cancer in very old women Am J Clin Oncol 25 2002 48 49
27. U. Veronesi, R. Orecchia, and A. Luini preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated Eur J Cancer 37 2001 2178 2183
28. J.S. Vaidya, D.J. Joseph, and J.S. Tobias Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial Lancet 376 2010 91 102
29. M. Baum, A.U. Buzdar, and J. Cuzick Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139
30. R.C. Coombes, E. Hall, and L.J. Gibson A randomised trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 350 2004 1081 1092
31. P.E. Goss, J.N. Ingle, and S. Martino Randomized trial of letrozole following tamoxifen as extended therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17 J Natl Cancer Inst 97 2005 1262 1271
32. K. Briot, M. Tubiana-Hulin, L. Bastit, I. Kloos, and C. Roux Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study Breast Cancer Res Treat 120 2010 127 134
33. I.S. Fentiman, Z. Saad, M.A. Chaudary, and I. Fogelman Tamoxifen protects against steroid induced bone loss Eur J Cancer 28 1992 684 685